An added feature to the EsoGLOVE™, the EsoGLOVE™ Myo, provides training via the acquisition of myoelectric signals through surface EMG (sEMG) sensors.
Detection of motor intention through sEMG, enabling early active therapy
Provide closed-loop biofeedback, promoting relearning of normal movement patterns
Flexor & extensor assessment, enabling therapists to monitor which muscle group is active, even without noticeable movements
EsoGLOVE™ Myo integrates sEMG sensors for upper limb therapy, incorporating graphical visualisation for recovery progress monitoring as part of a dynamic approach to monitor patients experience and performance. sEMG sensors provide biofeedback through continuous monitoring of muscle activity.
Additionally, EsoGLOVE™ Myo features a muscle signal assessments function of extensors and flexors, allows clinicians to observe changes in muscle activities while exploring different motor movements for that can aid in motor relearning during therapy.
"Regaining self reliance in the most natural and efficient way"
US FDA-registered Rehabilitation System
ISO13485:2016 Certification by TUV SUD
Biocompatibility tests per ISO10993-1 requirements
Electrical safety tests per IEC 60601-1 requirements
Electromagnetic compatibility tests per IEC 60601-1-2 requirements